Safety Data SheetChemical Risk Assessment

Telzir / Lexiva Tablets

by ViiV Healthcare

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Telzir / Lexiva Tablets is supplied by ViiV Healthcare under product code LEXIVA 700 MG TABLETS (US), TELZIR 700 MG TABLETS, FOSAMPRENAVIR CALCIUM 700 MG TABLETS, HIV 908 TABLETS 700 MG, GW433908G TAB LETS, FOSAMPRENAVIR CALCIUM, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 21 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
GHS/CLP
Revision Date
21 May 2018
Signal Word
WARNING
Product Code
LEXIVA 700 MG TABLETS (US), TELZIR 700 MG TABLETS, FOSAMPRENAVIR CALCIUM 700 MG TABLETS, HIV 908 TABLETS 700 MG, GW433908G TAB LETS, FOSAMPRENAVIR CALCIUM, FORMULATED PRODUCT
CAS Number
226700-81-8,9004-34-6,9003-39-8,557-04-0,13463-67-7,7631-86-9

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: WARNING

Health hazardGHS08Health hazard
EnvironmentGHS09Environment
Hazard Statements (H-phrases)
+548+EEC
See full Safety Data Sheet for the hazard statement wording.
H351
Suspected of causing cancer.
H373
May cause damage to organs through prolonged or repeated exposure.
H412
Harmful to aquatic life with long lasting effects.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US